Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Keiko Wanaka"'
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 31:325-333
Publikováno v:
Bioorganic & Medicinal Chemistry. 24:545-553
Based on the structure of YO-2 [N-(trans-4-aminomethylcyclohexanecarbonyl)- l -Tyr(O-picolyl)-NH-octyl], active site-directed plasmin (Plm) inhibitors were explored. The picolyl moiety in the Tyr(O-picolyl) residue (namely, the P2 residue) was replac
Publikováno v:
Proceedings of the 35th European Peptide Symposium.
Autor:
Arisa Masuda, Mitsuhito Araki, Eriko Akiduki, Tadamune Otsubo, Maiko Akagawa, Naoki Teno, Keiko Wanaka, Yukiko Yamashita, Keigo Gohda, Yuko Tsuda
Publikováno v:
Bioorganic & Medicinal Chemistry. 23:3696-3704
Here we report a series of plasmin inhibitors which were originally derived from the parent structure of 1 and 2. Our efforts focused on the optimization of the P4 moiety of 2 and on the quest of alternative scaffold to pyrrolopyrimidine in the paren
Autor:
Naoki Teno, Keigo Gohda, Yuko Tsuda, Tadamune Otsubo, Takuya Sueda, Yukiko Yamashita, Keiko Wanaka
Publikováno v:
Bioorganic & Medicinal Chemistry. 22:2339-2352
In the development of plasmin inhibitors, a novel chemotype, pyrrolopyrimidine scaffold possessing two motifs, a hydantoin-containing P4 moiety and a warhead-containing P1 moiety, is uncovered. A unique feature of the new line of the plasmin inhibito
Publikováno v:
Thrombosis Research. 135:127-129
Introduction Since heparin-induced thrombocytopenia (HIT), caused by the generation of antibodies against platelet factor 4 (PF4)/heparin complexes (HIT antibodies), may induce serious complications due to thrombosis, a prompt diagnosis is desirable.
Publikováno v:
Chemical Biology & Drug Design. 83:52-57
We here strove to overcome the limitations of expression analyses such as PCR and IHC, based on molecular recognition between target and probe molecules, by designing synthetic substrates specific to the target molecules to directly estimate the enzy
Autor:
Tadamune Otsubo, Yukiko Yamashita, Keigo Gohda, Keiko Wanaka, Yuko Tsuda, Naoki Teno, Masafumi Yamaguchi
Publikováno v:
Bioorganicmedicinal chemistry letters. 26(9)
In this letter we report the design and synthesis of a series of plasmin inhibitors, which share the amino acid-based linker with limited free rotation between the hydantoin moiety and the benzimidazole scaffold. Our studies led to potent plasmin inh
Autor:
Kiyoshi Ikeda, Yuko Tsuda, Takuya Sueda, Tadamune Otsubo, Akiko Hijikata-Okunomiya, Naoki Teno, Keiko Wanaka, Keigo Gohda
Publikováno v:
Journal of Peptide Science. 18:620-625
Plasmin is best known as the key molecule in the fibrinolytic system, which is critical for clot lysis and can initiate matrix metalloproteinase (MMP) activation cascade. Along with MMP, plasmin is suggested to be involved in physiological processes
Autor:
Margaret Prechel, Vicki Escalante, Chieko Kaneko, Mitsuru Oosawa, Jeanine M. Walenga, Kumiko Miyashita, Nobuhiro Hoshino, Miyako Matsuo, Reiko Asada, Keiko Wanaka
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 19:37-41
Quality control of the platelet activation assays to diagnose heparin-induced thrombocytopenia (HIT), (14)C-serotonin release assay (SRA) and platelet aggregation test (PAT) has yet to be established due to lack of reference standards and the difficu